Ritonavir Completed Phase 4 Trials for Tuberculosis Infection / Human Immunodeficiency Virus (HIV) Infections

IndicationsStatusPurposePhase
CompletedNot Available4
clinicaltrials.gov IdentifierTitleDrugs
NCT00771498An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin
NCT01375881Non-interventional Study on Use of Darunavir With Ritonavir in Clinical Practice
NCT00384904Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients
NCT00531557Double Protease Inhibitor to Darunavir Switch Study
NCT01541085An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART
NCT01615601An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients
NCT01232127Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection